# \[e-drug\] MSF report 'Fighting Neglect' on Chagas disease, sleeping sickness, kala azar

**URL:** <https://talk.edrugplus.org/t/e-drug-msf-report-fighting-neglect-on-chagas-disease-sleeping-sickness-kala-azar/37455>\
**Category:** e-drug\
**Created:** [June 14, 2012, 1:18pm UTC](https://talk.edrugplus.org/t/e-drug-msf-report-fighting-neglect-on-chagas-disease-sleeping-sickness-kala-azar/37455 "2012-06-14T13:18:09Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Michelle\_Vilk](https://avatars.discourse-cdn.com/v4/letter/m/85f322/32.png) [@Michelle\_Vilk](https://talk.edrugplus.org/u/Michelle_Vilk)\
**Post date:** [June 14, 2012, 1:18pm UTC](https://talk.edrugplus.org/t/e-drug-msf-report-fighting-neglect-on-chagas-disease-sleeping-sickness-kala-azar/37455/1 "2012-06-14T13:18:09Z")

</div>

E-DRUG: MSF report 'Fighting Neglect' on Chagas disease, sleeping sickness, kala azar  
------------------------------------------

Médecins Sans Frontières has this week launched its new report Fighting  
Neglect charting MSF's 25 years of experience in diagnosing and treating  
Chagas disease, sleeping sickness, and kala azar, in Latin America,  
Sub-Saharan Africa, South Asia and the Caucasus.

To read the report:  
[http://www.msfaccess.org/about-us/media-room/press-releases/neglected-tropical-diseases-new-msf-report-highlights-how-break](http://www.msfaccess.org/about-us/media-room/press-releases/neglected-tropical-diseases-new-msf-report-highlights-how-break)

"Fighting Neglect" charts MSF's 25 years of experience in diagnosing and  
treating Chagas disease, sleeping sickness, and kala azar, in Latin  
America, Sub-Saharan Africa, South Asia and the Caucasus. It examines  
past, present, and future management of the diseases and shows that  
treatment is possible even with existing diagnostic tools and medicines.  
However, additional research and development toward new and more effective  
diagnostics and treatments are desperately needed to address the  
overwhelming neglect of people whose needs fail to be met by  
pharmaceutical companies. It will take increased political will among  
international donors and national governments where these diseases are  
endemic to improve access to quality life-saving treatment.

Kind regards,

Michelle Vilk  
Coordination and Communications Assistant  
Médecins Sans Frontières - Access Campaign  
Rue de Lausanne 78  
1211 Geneva, Switzerland  
Tel: + 41(0) 22 849 89 02  
Fax: + 41 (0) 22 849 84 04  
michelle.vilk@geneva.msf.org  
www.msfaccess.org

Join MSF & tell Novartis that people matter more than profits. Take action  
and Stop Novartis:  
[http://www.msfaccess.org/STOPnovartis/](http://www.msfaccess.org/STOPnovartis/)
